233 results on '"Balan, Vijayan"'
Search Results
2. In a 12-Year Study, Sustainability of Quality of Life Benefits After Liver Transplantation Varies With Pretransplantation Diagnosis
3. Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C
4. Increased Prevalence of Reduced Estimated Glomerular Filtration Rate in Chronic Hepatitis C Patients
5. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation
6. Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy
7. Inpatient Admissions for Drug-induced Liver Injury: Results from a Single Center
8. Modafinil’s Use in Combating Interferon-Induced Fatigue
9. Pegylated Interferon and Ribavirin Failures: Is Retreatment an Option?
10. Portal Hypertension Due to a Splenic Arteriovenous Fistula: A Case Report
11. Liver Transplantation in the MELD Era: A Single-Center Experience
12. Successful Treatment With Novel Triple Drug Combination Consisting of Interferon-γ, Interferon Alfacon-1, and Ribavirin in a Nonresponder HCV Patient to Pegylated Interferon Therapy
13. Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients
14. Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?
15. Metabolic bone disease in patients with liver disease
16. Changes in B-lymphocyte stimulator protein levels during treatment with albinterferon alfa-2b in patients with chronic hepatitis C who have failed previous interferon therapy
17. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database
18. Erythropoietin Does Not Increase the Frequency of Thromboembolic Events or Hepatocellular Carcinoma in Hepatitis C Patients Treated With Combination Antiviral Therapy
19. Recurrence of autoimmune liver disease after liver transplantation: A systematic review
20. Albumin-interferon-α in the treatment of chronic hepatitis C
21. Pyogenic Liver Abscess After Colonoscopy in a Patient With Ulcerative Colitis
22. Recurrent primary sclerosing cholangitis: From an academic illusion to a clinical reality
23. Hepatic B-Cell Non-Hodgkinʼs Lymphoma of MALT Type in the Liver Explant of a Patient With Chronic Hepatitis C Infection
24. Liver transplant in a patient with a ventriculoperitoneal shunt
25. Lack of Association of Common Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations with Primary Sclerosing Cholangitis
26. Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin
27. Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
28. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
29. A Randomized, Double-blind, Placebo-controlled trial of interferon-α and amantadine versus interferon-α alone in the treatment of patients with Chronic Hepatitis C
30. Incidence and prevalence of coccidioidomycosis in patients with end-stage liver disease
31. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem
32. Outcome of liver transplantation for familial amyloidotic polyneuropathy
33. Disseminated histoplasmosis in a patient after orthotopic liver transplantation
34. Acute Hepatitis E by a New Isolate Acquired in the United States
35. LETTER: A Randomized, Double-Blind, Placebo-Controlled Trial of Interferon-α and Amantadine Versus Interferon-α Alone in the Treatment of Patients with Chronic Hepatitis C
36. AUTOIMMUNE LIVER DISEASES: Recurrence After Liver Transplantation
37. 1007-LBP
38. Perplexing Lesions of the Sinonasal Cavity and Skull Base: IgG4‐related and Similar Inflammatory Diseases
39. Treatment of Hepatitis C in Renal Transplantation Candidates: A Single-Center Experience
40. Severe Hepatotoxicity Caused by a Methasteron-containing Performance-enhancing Supplement
41. Selective Serotonin Reuptake Inhibitors in the Context of Hepatitis C Infection
42. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy
43. Infections in Patients With End-stage Liver Disease
44. Modulation of Interferon-Specific Gene Expression by Albumin-Interferon-α in Interferon-α-Experienced Patients with Chronic Hepatitis C
45. A Phase I/II Study Evaluating Escalating Doses of Recombinant Human Albumin-Interferon-α Fusion Protein in Chronic Hepatitis C Patients who have Failed Previous Interferon-α-Based Therapy
46. Pyogenic Liver Abscess Following Colonoscopy in a Patient with Ulcerative Colitis
47. Hepatitis C Virus Infection with Hepatocellular Carcinoma: Not A Controversial Indication for Liver Transplantation
48. Liver transplantation for hepatocellular carcinoma: The MELD impact
49. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single-center experience
50. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.